CNBC reports the PhaSeal System helps maintain sterility of drug in vial for up to 168 hours

CNBC published an electronic news story about a new study that concludes drug solutions could be expected to remain sterile for up to 168 hours if the PhaSeal device is applied properly and all additional USP <797> standards are followed.  This extended beyond-use dating could significantly reduce waste and cost of these products.  Read more.

PhaSeal on CNBC

PhaSeal Study featured on CNBC

Click here to read the study in its entirety.

Posted on March 2, 2011, in Uncategorized. Bookmark the permalink. Leave a comment.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: